NPASS Compound

Structure

NPC134619 OpenBabel06302216152D 22 25 0 0 1 0 0 0 0 0999 V2000 2.6699 -2.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0860 -1.2864 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 3.8288 -0.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8288 0.0001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0860 0.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3432 0.0001 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.3432 0.8322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3432 -0.8576 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.6005 -1.2865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8577 -0.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8577 0.0000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.1149 0.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1149 1.2866 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.8576 1.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6004 1.2866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6005 0.4289 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.3140 0.5438 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.1572 0.5438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7356 1.2741 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5021 -2.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3343 -2.0071 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 2 8 1 0 0 0 0 2 3 1 0 0 0 0 2 21 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 16 1 0 0 0 0 6 7 1 1 0 0 0 6 8 1 0 0 0 0 8 9 1 1 0 0 0 9 10 1 0 0 0 0 11 10 1 1 0 0 0 11 19 1 0 0 0 0 11 12 1 0 0 0 0 11 16 1 0 0 0 0 13 12 1 1 0 0 0 13 14 1 0 0 0 0 13 17 1 0 0 0 0 14 15 2 0 0 0 0 16 15 1 1 0 0 0 17 18 1 6 0 0 0 17 19 1 0 0 0 0 17 20 1 0 0 0 0 21 22 1 0 0 0 0 M END $$$$

Physi-Chem Properties

Molecular Weight:	304.24
Volume:	335.194
LogP:	3.683
LogD:	3.195
LogS:	-3.65
# Rotatable Bonds:	1
TPSA:	40.46
# H-Bond Aceptor:	2
# H-Bond Donor:	2
# Rings:	4
# Heavy Atoms:	2

MedChem Properties

QED Drug-Likeness Score:	0.721
Synthetic Accessibility Score:	6.079
Fsp3:	0.9
Lipinski Rule-of-5:	Accepted
Pfizer Rule:	Rejected
GSK Rule:	Accepted
BMS Rule:	0
Golden Triangle Rule:	Accepted
Chelating Alert:	0
PAINS Alert:	0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:	-4.651
MDCK Permeability:	1.585348400112707e-05
Pgp-inhibitor:	0.001
Pgp-substrate:	0.001
Human Intestinal Absorption (HIA):	0.004
20% Bioavailability (F20%):	0.008
30% Bioavailability (F30%):	0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):	0.247
Plasma Protein Binding (PPB):	82.0121078491211%
Volume Distribution (VD):	0.91
Pgp-substrate:	11.003890991210938%

ADMET: Metabolism

CYP1A2-inhibitor:	0.029
CYP1A2-substrate:	0.484
CYP2C19-inhibitor:	0.03
CYP2C19-substrate:	0.825
CYP2C9-inhibitor:	0.098
CYP2C9-substrate:	0.07
CYP2D6-inhibitor:	0.031
CYP2D6-substrate:	0.125
CYP3A4-inhibitor:	0.946
CYP3A4-substrate:	0.264

ADMET: Excretion

Clearance (CL):	9.583
Half-life (T1/2):	0.289

ADMET: Toxicity

hERG Blockers:	0.019
Human Hepatotoxicity (H-HT):	0.337
Drug-inuced Liver Injury (DILI):	0.027
AMES Toxicity:	0.006
Rat Oral Acute Toxicity:	0.217
Maximum Recommended Daily Dose:	0.301
Skin Sensitization:	0.739
Carcinogencity:	0.201
Eye Corrosion:	0.107
Eye Irritation:	0.303
Respiratory Toxicity:	0.904

Download Data

Data Type	Select
General Info & Identifiers & Properties
Structure MOL file
Source Organisms
Biological Activities
Similar NPs/Drugs

Natural Product: NPC134619

Natural Product ID:	NPC134619
*Common Name:**	JBPZDADYJLERCY-MCBVBLDDSA-N
IUPAC Name:	n.a.
Synonyms:
Standard InCHIKey:	JBPZDADYJLERCY-MCBVBLDDSA-N
Standard InCHI:	InChI=1S/C20H32O2/c1-17(13-21)8-4-9-18(2)15(17)7-10-20-11-14(5-6-16(18)20)19(3,22)12-20/h5-6,14-16,21-22H,4,7-13H2,1-3H3/t14-,15-,16+,17-,18-,19-,20+/m1/s1
SMILES:	C[C@@]1(CCC[C@]2(C)[C@@H]1CC[C@]13C[C@@H](C=C[C@@H]23)[C@@](C)(C1)O)CO
Synthetic Gene Cluster:	n.a.
ChEMBL Identifier:	n.a.
PubChem CID:	n.a.
Chemical Classification:**	CHEMONTID:0000000 [Organic compounds] [CHEMONTID:0000012] Lipids and lipid-like molecules [CHEMONTID:0000259] Prenol lipids [CHEMONTID:0001551] Diterpenoids [CHEMONTID:0003782] Kaurane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

Species Source

Organism ID	Organism Name	Taxonomy Level	Family	SuperKingdom	Isolation Part	Collection Location	Collection Time	Reference
NPO3497	Pestalotiopsis virgatula	Species	Sporocadaceae	Eukaryota	n.a.	mycelium	n.a.	PMID[21942847]
NPO1778	Corydalis claviculata	Species	Papaveraceae	Eukaryota	n.a.	n.a.	n.a.	Database[HerDing]
NPO1778	Corydalis claviculata	Species	Papaveraceae	Eukaryota	n.a.	n.a.	n.a.	Database[TCMID]
NPO25853	Sideritis argosphacelus	Species	Lamiaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO11159	Isoplexis chalcantha	Species	Plantaginaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO9533	Pterocaulon polystachyum	Species	Asteraceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO11287	Sideritis lotsyi	Species	Lamiaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO12897	Dolichospermum viguieri	Species	Aphanizomenonaceae	Bacteria	n.a.	n.a.	n.a.	Database[UNPD]
NPO1778	Corydalis claviculata	Species	Papaveraceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO5068	Hyrtios eubamma	Species	Thorectidae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO9377	Ormosia elata	Species	Limoniidae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO11050	Cladonia amaurocraea	Species	Cladoniaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO6630	Cetraria pinastri	Species	Parmeliaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO150	Echinops niveus	Species	Asteraceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO3497	Pestalotiopsis virgatula	Species	Sporocadaceae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]
NPO2126	Asterias forbesi	Species	Asteriidae	Eukaryota	n.a.	n.a.	n.a.	Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

NP Quantity Composition/Concentration

Organism ID	NP ID	Organism Material Preparation	Organism Part	NP Quantity (Standard)	NP Quantity (Minimum)	NP Quantity (Maximum)	Quantity Unit	Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

Biological Activity

Target ID	Target Type	Target Name	Target Organism	Activity Type	Activity Relation	Value	Unit	Reference

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

● The left chart: Distribution of similarity level between NPC134619 and all remaining natural products in the NPASS database.
● The right table: Most similar natural products (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	144
0.1-0.2	1364
0.2-0.3	9139
0.3-0.4	14717
0.4-0.5	6873
0.5-0.6	5814
0.6-0.7	3526
0.7-0.8	886
0.8-0.85	145
0.85-0.9	73
0.9-0.95	16
0.95-1	0

Similarity Score	Similarity Level	Natural Product ID

Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

● The left chart: Distribution of similarity level between NPC134619 and all drugs/candidates.
● The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

range	Tanimoto Coefficient
0-0.1	136
0.1-0.2	1599
0.2-0.3	4619
0.3-0.4	1954
0.4-0.5	412
0.5-0.6	161
0.6-0.7	151
0.7-0.8	87
0.8-0.85	20
0.85-0.9	7
0.9-0.95	4
0.95-1	0

Similarity Score	Similarity Level	Drug ID	Developmental Stage

Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity

B: biological targets similarity

C: networks similarity

D: cell-based bioactivity similarity

E: similarity based on clinical data